TransMedics Group, Inc. (TMDX) /
The cash flow of TransMedics Group, Inc. over the past 8 years
Chart TransMedics Group, Inc.: operating cash flow, capital expenditures, free cash flow, fiscal 2018–2025 Open the chart →In fiscal 2025, the latest fiscal year on file, TransMedics Group, Inc.'s operating cash flow was $192.84M and its capital expenditures $59.25M, leaving free cash flow of $133.59M. Free cash flow was above zero in 1 of the 8 years shown. It ranged from -$164.88M in fiscal 2023 to $133.59M in fiscal 2025. Capital expenditures were highest in fiscal 2023, at $151.85M.
Year by year
| Fiscal year | Operating cash flow | Capital expenditures | Free cash flow* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $192.84M | $59.25M | $133.59M |
| 2024ended Dec 31, 2024 | $48.8M | $129.74M | -$80.94M |
| 2023ended Dec 31, 2023 | -$13.03M | $151.85M | -$164.88M |
| 2022ended Dec 31, 2022 | -$45.82M | $11.91M | -$57.72M |
| 2021ended Dec 31, 2021 | -$28.86M | $3.52M | -$32.38M |
| 2020ended Dec 31, 2020 | -$30.27M | $455K | -$30.72M |
| 2019ended Dec 28, 2019 | -$32.29M | $165K | -$32.45M |
| 2018ended Dec 29, 2018 | -$25.98M | $418K | -$26.4M |
Fiscal years as TransMedics Group, Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on TransMedics Group, Inc.
- The revenue of TransMedics Group, Inc.
- The profitability of TransMedics Group, Inc.
- The debt of TransMedics Group, Inc.
- All of TransMedics Group, Inc.'s financials, charted
Companies of a similar size
Not investment advice. This page shows what TransMedics Group, Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.